Clearance studies in patients with acute renal failure treated by continuous arteriovenous haemodialysis.
Davies
S P
SP
Charing Cross and Westminister Medical School, London, UK.
Kox
W J
WJ
Brown
E A
EA
D058186:Acute Kidney Injury / Q000097:blood / Q000628:therapy*; D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics*; D003404:Creatinine / Q000097:blood; D004077:Digoxin / Q000493:pharmacokinetics; D006440:Hemofiltration; D006801:Humans; D008657:Metabolic Clearance Rate; D008970:Molecular Weight; D010710:Phosphates / Q000097:blood; D006435:Renal Dialysis; D014508:Urea / Q000097:blood; D014527:Uric Acid / Q000097:blood; D001613:beta 2-Microglobulin / Q000378:metabolism*
D000900:Anti-Bacterial Agents; D010710:Phosphates; D001613:beta 2-Microglobulin; D014527:Uric Acid; D004077:Digoxin; D014508:Urea; D003404:Creatinine